Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Strategy for cross-protection among Shigella flexneri serotypes

F R Noriega¹, F M Liao, D R Maneval

¹Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. fnoriega@us.pmc-vacc.com

Infection and Immunity

|January 23, 1999

Summary

A novel vaccine strategy using two Shigella flexneri serotypes (2a and 3a) demonstrated broad cross-protection in animal models. This approach targets major antigenic factors for enhanced Shigella vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Factors associated with typical enteropathogenic <i>Escherichia coli</i> infection among children <5 years old with moderate-to-severe diarrhoea in rural western Kenya, 2008-2012.

Epidemiology and infection·2020

Same author

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants.

Vaccine·2019

Same author

Diarrhoea, enteric pathogen detection and nutritional indicators among controls in the Global Enteric Multicenter Study, Kenya site: an opportunity to understand reference populations in case-control studies of diarrhoea.

Epidemiology and infection·2018

Same author

Overexpression of O-polysaccharide chain length regulators in Gram-negative bacteria using the Wzx-/Wzy-dependent pathway enhances production of defined modal length O-polysaccharide polymers for use as haptens in glycoconjugate vaccines.

Journal of applied microbiology·2018

Same author

Biohydrogenation of cholesterol as an index of bacterial 7α-dehydroxylase activity.

Lipids·2016

Same author

Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.

Mucosal immunology·2015

Area of Science:

Microbiology
Immunology
Vaccine Development

Background:

Shigella flexneri, a leading cause of bacterial dysentery, exhibits significant serotype diversity.
Lipopolysaccharide (LPS) structure and antigenicity are key targets for developing broad-spectrum Shigella vaccines.

Purpose of the Study:

To design and evaluate a vaccine strategy for broad cross-protection against Shigella group B using two specific serotypes.
To assess the immunogenicity and protective efficacy of novel attenuated Shigella flexneri strains.

Main Methods:

Development of attenuated Shigella flexneri 2a (CVD 1207) and 3a (CVD 1211) strains.
Immunization of guinea pigs with a mixture of the two attenuated strains.
Challenge studies using virulent wild-type Shigella flexneri serotypes and serological assays (ELISA, immunoblotting, slide agglutination).

Related Experiment Videos

Main Results:

Immunization induced serum and mucosal antibodies cross-reactive with multiple S. flexneri serotypes (excluding serotype 6).
The vaccine combination provided significant protection against challenge with S. flexneri serotypes 1b, 2b, 5b, and Y.
Protection was not observed against S. flexneri serotypes 1a, 4b, and 6.

Conclusions:

A bivalent vaccine strategy using S. flexneri 2a and 3a demonstrates potential for broad cross-protection against Shigella group B.
The study highlights the importance of targeting major antigenic group factors for effective Shigella vaccine design.
Further research is warranted to optimize vaccine efficacy against all targeted serotypes.